capitolbuilding
Issue Background

Federal Legislation

Infection Prevention Funding in FY 2020

Below is a chart outlining how infection prevention programs fared this year when compared to the previous year. 

Federal Government Program

FY 2019

FY 2020

Emerging and Zoonotic Infectious Diseases Programs

   

Antibiotic Resistance Initiative

$168,000,000

$168,000,000

National Healthcare Safety Network

$21,000,000

$21,000,000

Advanced Molecular Detection

$30,000,000

$30,000,000

Prevention and Public Health Fund (PPHF)

   

Immunizations

$324,350,000

$320,500,000

Epidemiology and Lab Capacity program

$40,000,000

$40,000,000

Healthcare-Associated Infections

$12,000,000

$12,000,000

Agency for Healthcare Research and Quality (AHRQ)

   

AHRQ baseline funding

$334,000,000

$338,000,000

Healthcare-Associated Infections Prevention

$36,000,000

$36,000,000

National Institutes of Health (NIH)

   

National Institute of Allergy and Infectious Diseases

$5,260,210,000

$5,523,000,000



 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019 Testimony and Coalition Letters

  • December 11, 2019
    The Adult Vaccine Access Coalition sent a letter a letter to Robert Kadlec, MD, Assistant Secretary for Preparedness and Response, about the President’s Executive Order (EO) directing the US Department of Health and Human Services to overhaul seasonal flu vaccine production and urge more Americans to be vaccinated.
  • November 11, 2019
    The Stakeholder Forum on Antimicrobial Resistance (S-FAR) sent a letter encouraging Secretary Azar to include a request 
    for antibiotic incentives in the upcoming supplemental funding bill to research a universal flu vaccine. 
  • November 11, 2019
    The Stakeholder Forum on Antimicrobial Resistance (S-FAR) sent a letter to House and Senate Appropriators asking them to support key programs promoting antibiotic stewardship and combating antimicrobial resistance. 
  • September 13, 2019
    The Stakeholder Forum on Antimicrobial Resistance (S-FAR) sent a letter encouraging Secretary Azar to support incentives to increase the antibiotic pipeline.
  • August 15, 2019 
    The American Academy of Allergy, Asthma & Immunology sent a letter encouraging the FDA to expedite the review process process on penicillin skin testing. 
  • July 8, 2019
    The S-FAR sent a letter supporting the DISARM Act, which is an effort to help restructure Medicare reimbursements for antibiotics. 
  • June 21, 2019
    The CDC Coalition sent a letter to the U.S. Senate Appropriations Committee urging the Senate to match increased funding levels that passed through the House of Representatives. 
  • June 18, 2019
    The Trust for America's Health (TFAH) sent a letter to sponsors of the Prevention and Public Health Funding (PPHF) Restoration Act, which restores the PPHF to its initial funding targets for this fiscal year. 
  • June 10, 2019 
    The Trust for America's Health sent a letter of support for the LIFT America Act, which is a broad infrastructure package which has provisions for improvements to public health laboratories, public health data modernization, state, local, tribal and territorial core public health infrastructure, and CDC's core public health infrastructure.
  • April 24, 2019
    APIC sent a letter to the Pennsylvania Senate Health Committee supporting efforts to require surgical technicians and sterile processors be certified prior to practice.
     
  • April 8, 2019 
    APIC and SHEA sent joint testimony to the House Appropriations Committee supporting HAI, Vaccines, and antibiotic resistance programs. 
  • March 25, 2019
    The Data: Elemental to Health Campaign Coalition sent a letter supporting $100 million in funding for FY 2020 to modernize its data platforms, and support the modernization/implementation of systems at state and local health departments. 
  • March 11, 2019
    The Stakeholder Forum on Antimicrobial Resistance sent a letter to the House and Senate Appropriations Committees requesting funding for key infection prevention and control programs.  
  • March 7, 2019
    The Friends of AHRQ coalition sent a letter requests Congress provide the Agency for Healthcare Research and Quality (AHRQ) $460 million in funding for FY 2020. 
  • March 4, 2019
    The CDC Coalition sent a letter urging the House and Senate Appropriations Committees to provide $7.8 billion in funding for the CDC. 
  • February 15, 2019 
    The Nondefense Discretionary sent a letter to Members of Congress to protect nondefense discretionary programs in the FY 2019 budget.  
  • February 14, 2019
    APIC sent a letter to the California Department of Public Health as there were revisiting infection prevention regulations in the state. 

2018 Testimony and Coalition Letters

  • On September 7, the Friends of AHRQ coalition sent a letter requesting the House and Senate Appropriations Committees continue to fund AHRQ at a minimum of $334 million. 
  • On July 12, the Stakeholder Forum on Antimicrobial Resistance (S-FAR) sent a letter expressing support for the REVAMP Act: Re-Valuing Antimicrobial Products of 2018 (H.R.6294) which encourages companies to invest in new antimicrobials by allowing anyone creating a new antibiotic an additional year of exclusivity for another drug. 
  • On June 13, the CDC Coalition sent a letter expressed opposition to using the Prevention and Public Health Fund to offset projected spending in the Puerto Rice Economic Empowerment Act. 
  • On June 8, the Stakeholder Forum on Antimicrobial Resistance (S-FAR) sent a letter to members of the Appropriations Committee requesting funding for key infection prevention and control programs. 
  • On April 26, APIC and SHEA submitted joint testimony to the House Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies asking the subcommittee to support key infection prevention programs.  
  • On April 9, the CDC Coalition submitted a letter to the House and Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies requesting them to fund the CDC at $8.445 billion. 
  • On March 19, APIC joined a coalition letter being led by the American Thoracic Society requesting members of Congress increase funding for domestic and international tuberculosis programs. 
  • On March 12, APIC joined a coalition letter urging the Assistant Secretary for Preparedness and Response (R&D) support new antimicrobial research and development (R&D) incentives in the reauthorization of the Pandemic and All Hazards Preparedness Act (PAHPA).
  • On February 26, APIC joined a S-FAR coalition letter in supporting the Strategies to Address Antimicrobial Resistance (STAAR) Act which was introduced by Senator Sherrod Brown. 
  • On February 6, a coalition of more than 50 organizations signed a letter encouraging Members of Congress to include an amendment to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization legislation. The letter encourages legislators to incentivize companies to develop new antimicrobials.
  • APIC signed another coalition letter asking Members of Congress not to cut any more funding from the Prevention and Public Health Fund. 
  • On January 8, APIC joined the Friends of AHRQ on a coalition letter asking Members of Congress to support equal or higher funding for the Agency for Healthcare Research and Quality (AHRQ)